Search results for "Anticoagulation"
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://immattersacp.org/weekly/archives/2020/10/20/5.htm
20 Oct 2020
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
MKSAP Quiz: Preconception counseling for mitral stenosis
A 26-year-old woman seeks preconception counseling. She has a history of mitral stenosis and underwent mitral valve replacement with a tilting-disc mechanical prosthesis 5 years ago. Following a physical exam, lab studies, and electrocardiogram, what is the most appropriate anticoagulation regimen for this patient during the first trimester?
https://immattersacp.org/weekly/archives/2020/06/23/3.htm
23 Jun 2020
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
MKSAP Quiz: Evaluation for easy bruising
A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Following a physical exam and lab studies, what is the most appropriate diagnostic test?
https://immattersacp.org/weekly/archives/2023/03/28/3.htm
28 Mar 2023
NOACs linked to lower rates of diabetes complications than warfarin in patients with afib and diabetes
A retrospective study from Taiwan found that patients who received non-vitamin K antagonist oral anticoagulants (NOACs) developed fewer macrovascular and microvascular complications, had fewer glycemic emergencies, and were less likely to die than those who received warfarin.
https://immattersacp.org/weekly/archives/2022/02/15/2.htm
15 Feb 2022
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low
A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://immattersacp.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012